Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane vs Propofol in Hepatobiliary Surgery
NCT03772106Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Jun 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of propofol injection (veterinary) and sevoflurane in hepatobiliary diseases (2 arms), sponsored by Ghent University Hospital. Primary endpoint: Change in blood flow in hepatic artery and main portal vein. Started Jun 2017; status: completed.
02
Drugs
propofol injection (veterinary)sevoflurane
03
Conditions
hepatobiliary diseases
Beyond the preview
Go deeper on NCT03772106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03772106.